20
Chongqing Daxin Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is VANCOMYCIN HYDROCHLORIDE, with a corresponding US DMF Number 24185.
Remarkably, this DMF maintains an Active status since its submission on September 17, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 12, 2014, and payment made on June 13, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II